MX2016005092A - Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos. - Google Patents
Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.Info
- Publication number
- MX2016005092A MX2016005092A MX2016005092A MX2016005092A MX2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A MX 2016005092 A MX2016005092 A MX 2016005092A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- pharmaceutical compositons
- vaginal
- estradiol pharmaceutical
- vaginal inserted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
De conformidad con varias modalidades de la presente descripción, se proporcionan composiciones farmacéuticas que comprenden estradiol solubilizado. En varias modalidades, dichas composiciones se encapsulan en cápsulas blandas que pueden insertarse en la vagina para el tratamiento de la atrofia vulvovaginal.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361889483P | 2013-10-10 | 2013-10-10 | |
US201361894411P | 2013-10-22 | 2013-10-22 | |
US14/099,562 US8987237B2 (en) | 2011-11-23 | 2013-12-06 | Natural combination hormone replacement formulations and therapies |
US201461932140P | 2014-01-27 | 2014-01-27 | |
PCT/US2014/061811 WO2015073177A1 (en) | 2013-10-10 | 2014-10-22 | Vaginal inserted estradiol pharmaceutical compositons and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016005092A true MX2016005092A (es) | 2016-08-17 |
Family
ID=53140634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016005092A MX2016005092A (es) | 2013-10-10 | 2014-10-22 | Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos. |
Country Status (3)
Country | Link |
---|---|
CA (1) | CA2926342A1 (es) |
MX (1) | MX2016005092A (es) |
WO (1) | WO2015073177A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
AU2020397648B2 (en) | 2019-12-06 | 2022-03-24 | Prathima Chowdary | Sustained release estrogen vaginal ring pessary for treatment of atrophy, cystitis and uterovaginal prolapse |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1300799A (en) * | 1997-11-03 | 1999-05-24 | Deschutes Medical Products, Inc. | Pessary with medicated cartridge |
MX367596B (es) * | 2012-01-26 | 2019-08-27 | Therapeuticsmd Inc | Tratamientos transdermicos de sustitucion hormonal. |
US20130224268A1 (en) * | 2012-02-27 | 2013-08-29 | Newgen Biopharma Corp. | Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |
-
2014
- 2014-10-22 MX MX2016005092A patent/MX2016005092A/es unknown
- 2014-10-22 WO PCT/US2014/061811 patent/WO2015073177A1/en active Application Filing
- 2014-10-22 CA CA2926342A patent/CA2926342A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2015073177A8 (en) | 2016-07-07 |
CA2926342A1 (en) | 2015-05-21 |
WO2015073177A1 (en) | 2015-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014015899A (es) | Capsula de estradiol soluble para insercion por via vaginal. | |
PH12016500024A1 (en) | Bromodomain inhibitor | |
PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
PH12015501648B1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
TN2013000310A1 (en) | Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections | |
MX2015009106A (es) | Composiciones de solución sólida y su uso en el tratamiento del dolor intenso. | |
IN2015MN00478A (es) | ||
TN2012000161A1 (en) | Spiro-oxindole mdm2 antagonists | |
IN2013MU03583A (es) | ||
TN2015000411A1 (en) | Ceftolozane antibiotic compositions | |
MX2016005092A (es) | Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos. | |
TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
MX2016008150A (es) | Formulaciones de berberina y usos de las mismas. | |
MX2015016410A (es) | Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos. | |
PH12015502564B1 (en) | Pyridone derivatives for the treatment of viral infections and further diseases | |
MX2015016603A (es) | Composiciones de corticosteroides. | |
EA201492238A1 (ru) | Композиция мизопростола | |
MX2022002614A (es) | El uso de un pesario que comprende una capsula que contiene estradiol y un agente solubilizante para el tratamiento de la atrofia vulvovaginal. | |
MX2016004961A (es) | Procedimientos y composiciones para el tratamiento de infecciones por s. equi. | |
EP3386514A4 (en) | VAGINALLY INTRODUCED STRADIOL PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS | |
SG10201810362SA (en) | Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition | |
UA92840U (uk) | Дегідратаційно-дегреасингаційний розчин для пластинації анатомічних препаратів | |
MY180947A (en) | Ceftolozane antibiotic compositions | |
IN2013CH02437A (es) | ||
MX2016001694A (es) | Formulacion de vacuna de sacarido. |